We are pleased to announce that the 2nd CA of JA3 WP4 on “Repetitive transcranial magnetic stimulation for treatment-resistant major depression” is available.
A call for Expression of Interest to participate in EUnetHTA JA3 Early Dialogues has now been published.
We are pleased to announce that the 1st Collaborative Assessment of WP4 AC-B on “Wearable cardioverter-defibrillator (WCD) therapy in primary and secondary prevention of sudden cardiac arrest in patients at risk” is ready now available.
The EC-EUnetHTA Forum "European cooperation on HTA: what's next?" co-organised by the European Commission and the EUnetHTA Joint Action 3 was the first meeting between all 79 EUnetHTA partner organisations and the broader HTA stakeholder community.
The Forum entitled “European Cooperation on HTA: What’s next?” is jointly organized by the European Commission and EUnetHTA and EC on the 21st of October 2016 in Brussels (The Square conference center).